| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/08/2006 | US20060121577 Comprises polynucleotides coding proteins associated with generating macrolide antibiotics; bactericides; polyketide synthase |
| 06/08/2006 | US20060121576 Maltose-1-phosphate-producing enzyme |
| 06/08/2006 | US20060121573 Production of proteins |
| 06/08/2006 | US20060121572 Production of heterologous proteins in Caulobacter |
| 06/08/2006 | US20060121571 encode a polypeptide having oxalate degrading activity |
| 06/08/2006 | US20060121570 Methods for producing polypeptide binding sites, monoclonal antibodies and compositions thereof |
| 06/08/2006 | US20060121566 Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor |
| 06/08/2006 | US20060121565 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 06/08/2006 | US20060121564 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 06/08/2006 | US20060121563 Novel tricistronic vectors and uses therefor |
| 06/08/2006 | US20060121561 Gene for increased somatic recombination |
| 06/08/2006 | US20060121560 DNA fragment to promote translation reaction and method for cell-free protein synthesis system using the same |
| 06/08/2006 | US20060121558 comprises a disruption in one or more gdhA, gpmB aceE, ppc, talB fdhF genes; higher yields; astaxanthin, canthaxanthin, beta-carotene, lycopene, phytoene or zeaxanthin |
| 06/08/2006 | US20060121556 Process for producing canthaxanthin |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121528 Recombinant Candida rugosa lipases |
| 06/08/2006 | US20060121527 Oncoprotein protein kinase |
| 06/08/2006 | US20060121526 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 06/08/2006 | US20060121523 Transporter genes OATP-B, C, D, and E |
| 06/08/2006 | US20060121522 Stimulating an immune response in human or animal, by administering a gene which LACKS A FUNCTIONAL VHS GENE, lacks a functional gene encoding ICP47, COMPRISES A FUNCTIONAL UL43 GENE, to infect DENDRITIC CELLS; increase gene expression on the surface of tumour cells; protection against cancer; vaccines |
| 06/08/2006 | US20060121520 Method for rapid detection and identification of bioagents |
| 06/08/2006 | US20060121518 Polypeptide encoded by nucleic acid of given sequence; Glycerol-3-phosphate; modulators of cellular metabolism, energy homeostasis, signal transduction and cell proliferation |
| 06/08/2006 | US20060121517 Screening methods involving the detection of short-lived proteins |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121513 Nuclear targeting sequence |
| 06/08/2006 | US20060121506 light emitting compositions that comprise a polymeric matrix having dissolved therein a photoactive compound; kits for use in an assay |
| 06/08/2006 | US20060121498 Enzymes involved in apoptosis |
| 06/08/2006 | US20060121495 Methods for disease detection |
| 06/08/2006 | US20060121489 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 06/08/2006 | US20060121488 Glutamate transport modulatory compounds and methods |
| 06/08/2006 | US20060121484 From mouse bone marrow; immunoglobulins; vectors, host cells; allergies |
| 06/08/2006 | US20060121478 Actn3 genotype screen for athletic performance |
| 06/08/2006 | US20060121475 Protein kinases |
| 06/08/2006 | US20060121474 Bio-chip prepared by gelation on a chip substrate |
| 06/08/2006 | US20060121471 Gene families associated with stomach cancer |
| 06/08/2006 | US20060121470 Multi-step synthesis of templated molecules |
| 06/08/2006 | US20060121466 Hammerhead ribozymes |
| 06/08/2006 | US20060121465 Sgk and nedd used as diagnostic and therapeutic targets |
| 06/08/2006 | US20060121464 Screening methods |
| 06/08/2006 | US20060121461 Methods for identifying and isolating unique nucleic acid sequences |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121458 High throughput separation and detection of nucleotide sequences and single nucleotide polymorphisms; anealing, replication, hybridization; ligation-dependent amplification assay followed by multiple injection; sequence determination; multichannel electrophoresis; complementary target-specific sections |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121448 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 06/08/2006 | US20060121447 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 06/08/2006 | US20060121446 Device and method for electroporation-based delivery of molecules into cells and dynamic monitoring of cell responses |
| 06/08/2006 | US20060121441 Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith |
| 06/08/2006 | US20060121056 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 06/08/2006 | US20060121050 Fusion protein comprising bacillus calmette guerin heat shock protein 65 and the epitope of human prostate specific antigen |
| 06/08/2006 | US20060121049 Chimeric recombinant protein and in vitro diagnosis |
| 06/08/2006 | US20060121048 Encoding at least two full-length mannose-6-phosphate receptors in the antisense configuration, vaccines |
| 06/08/2006 | US20060121041 Gpcs as modifiers of the irrtk p21 pathways and methods of use |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | US20060121013 Use of negative regulatory elements for the neurospecific expression of transgenes |
| 06/08/2006 | US20060121012 An implantable device coated with a matrix-bound ligand that binds the cell membrane markers of genetically altered mammalian cells and express and secrete at least one therapeutic gene product; vascular diseases; anticarcinogenic agents |
| 06/08/2006 | US20060121011 Combination gene delivery vehicles |
| 06/08/2006 | US20060121010 Chorionic gonadotropin DNA vaccines and methods |
| 06/08/2006 | US20060121009 Apparatus and method for machining michrochamber for cell culture |
| 06/08/2006 | US20060121008 Primarily cultured adipocytes for gene therapy |
| 06/08/2006 | US20060121002 Methods and compositions for tissue regeneration |
| 06/08/2006 | US20060121000 Methods and vectors for controlling gene expression |
| 06/08/2006 | US20060120999 Protein and peptide expression for passive immunity |
| 06/08/2006 | US20060120996 Vaccine immunotherapy for immune suppressed patients |
| 06/08/2006 | DE10251547B4 Rekombinante (R)-Hydroxynitrillyase Recombinant (R) -hydroxynitrile |
| 06/08/2006 | DE10233958B4 Restriktionsendonucleasen, Verfahren zu ihrer Herstellung und ihre Verwendung Restriction endonucleases, to processes for their preparation and their use |
| 06/08/2006 | DE102004057291A1 Lagerungsinduzierter Promotor Storage-induced promoter |
| 06/08/2006 | DE102004050410A1 Polypeptid mit Phytaseaktivität und dieses codierende Nucleotidsequenz Polypeptide having phytase activity and this encoding nucleotide sequence |
| 06/08/2006 | DE10145553B4 Nukleinsäure für einen Klonierungsvektor Nucleic acid for a cloning vector |
| 06/08/2006 | CA2631592A1 Photoporation of cells |
| 06/08/2006 | CA2631240A1 Methods and materials for expression of a recombinant protein |
| 06/08/2006 | CA2601629A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | CA2595115A1 Fusion proteins for treating, preventing or ameliorating pain |
| 06/08/2006 | CA2593707A1 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 06/08/2006 | CA2593429A1 The lupac bifunctional marker and its use in protein production |
| 06/08/2006 | CA2590583A1 Use of endosialin binding proteins to isolate endosialin positive cells |
| 06/08/2006 | CA2589725A1 Trichoderma reesei glucoamylase and homologs thereof |
| 06/08/2006 | CA2589538A1 Method of screening antiobesity agents |
| 06/08/2006 | CA2588984A1 Plants transformed with a nucleic acid encoding a mutated a type cyclin dependent kinase having increased yield and methods for making the same |
| 06/08/2006 | CA2588980A1 Vasopressin-binding l-nucleic acid |
| 06/08/2006 | CA2588900A1 Novel mutation involved in increased tolerance to imidazolinone herbicides in plants |
| 06/08/2006 | CA2588372A1 Stress tolerance in plants through selective inhibition of trehalose-6-phosphate phosphatase |
| 06/08/2006 | CA2588330A1 Methods of increasing seed yield with a growth eif-5a |
| 06/08/2006 | CA2588292A1 Non-cytotoxic protein conjugates |
| 06/08/2006 | CA2588129A1 Apoptosis-specific eif-5a and polynucleotides encoding same |
| 06/08/2006 | CA2587962A1 Highly branched hk peptides as effective carriers of sirna |
| 06/08/2006 | CA2587507A1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 06/08/2006 | CA2587493A1 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 06/08/2006 | CA2587438A1 Production of proteins involving galk1 complementation |
| 06/08/2006 | CA2526304A1 Expression cassettes for vascular tissue-preferential expression in plants |
| 06/08/2006 | CA2489940A1 Relay vaccine |
| 06/07/2006 | EP1667500A1 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 06/07/2006 | EP1666883A1 Diagnostic and monitoring methods for bone loss |
| 06/07/2006 | EP1666881A2 Diagnostic markers of acute coronary syndromes and methods of use thereof |
| 06/07/2006 | EP1666601A1 Transformant having an increased frequency of homologous recombination |
| 06/07/2006 | EP1666600A1 Methods for enhancing the efficacy of cancer therapy |
| 06/07/2006 | EP1666599A2 Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants |
| 06/07/2006 | EP1666598A1 Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene |
| 06/07/2006 | EP1666597A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666596A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666595A1 GAB2 (P97) gene and methods of use thereof |